Bucuvalas J, Yazigi N, Squires Jr RH. Acute liver failure in children. Clin Liver Dis. 2006;10:149–68.
Sarin SK, Kumar A, Almeida JA, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int. 2009;3:269–82.
Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41:1179–97.
Squires Jr RH, Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148:652–8.
Dhawan A, Cheeseman P, Mieli-Vergani G. Approaches to acute liver failure in children. Pediatr Transplant. 2004;8:584–8.
Arora NK, Nanda SK, Gulati S, et al. Acute viral hepatitis types E, A, and B singly and in combination in acute liver failure in children in north India. J Med Virol. 1996;48:215–21.
Bendre SV, Bavdekar AR, Bhave SA, Pandit AN, Chitambar SD, Arankalle VA. Fulminant hepatic failure: etiology, viral markers and outcome. Indian Pediatr. 1999;36:1107–12.
Poddar U, Thapa BR, Prasad A, Sharma AK, Singh K. Natural history and risk factors in fulminant hepatic failure. Arch Dis Child. 2002;87:54–6.
Mohan N. Hepatic failure and encephalopathy. In: Sachdev HPS, Choudhury P, Bagga A, Chugh K, Ramji S, Puri RK, editors. Principles of pediatric & neonatal emergencies. 2nd ed. New Delhi: Jaypee Brothers Medical Publishers Ltd; 2004. p. 236–44.
Bhowmick K, Mammen A, Moses PD, Agarwal I, Mathew L, Kang G. Hepatitis A in pediatric acute liver failure in southern India. Indian J Gastroenterol. 2005;24:34.
Samanta T, Ganguly S. Aetiology, clinical profile and prognostic indicators for children with acute liver failure admitted in a teaching hospital in Kolkata. Trop Gastroenterol. 2007;28:135–9.
Durand P, Debray D, Mandel R, et al. Acute liver failure in infancy: a 14-year experience of a pediatric liver transplantation center. J Pediatr. 2001;139:871–6.
Record CO, Iles RA, Cohen RD, Williams R. Acid-base and metabolic disturbances in fulminant hepatic failure. Gut. 1975;16:144–9.
Nelson DC, McGrew Jr WR, Hoyumpa Jr AM. Hypernatremia and lactulose therapy. JAMA. 1983;249:1295–8.
Ahya SN, Jose Soler M, Levitsky J, Batlle D. Acid-base and potassium disorders in liver disease. Semin Nephrol. 2006;26:466–70.
Heinemann HO, Emirgil C. Hypokalemia in liver disease. Metabolism. 1960;9:869–79.
Trocki O, Wotton MJ, Cleghorn GJ, Shepherd RW. Value of total body potassium in assessing the nutritional status of children with end-stage liver disease. Ann NY Acad Sci. 2000;904:400–5.
Quiros-Tejeira RE, Molina RA, et al. Resolution of hypophosphatemia is associated with recovery of hepatic function in children with fulminant hepatic failure. Transpl Int. 2005;18:1061–6.
Baquerizo A, Anselmo D, Shackleton C, et al. Phosphorus as an early predictive factor in patients with acute liver failure. Transplantation. 2003;75:2007–14.
Chung PY, Sitrin MD, Te HS. Serum phosphorus levels predict clinical outcome in fulminant hepatic failure. Liver Transpl. 2003;9:248–53.
Arora NK, Mathur P, Ahuja A, Oberoi A. Acute liver failure. Indian J Pediatr. 2003;70:73–9.
Murphy N, Auzinger G, Bernel W, Wendon J. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology. 2004;39:464–70.
Macdougall BR, Bailey RJ, Williams R. H2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Two controlled trials. Lancet. 1977;1:617–9.
O’Beirne JP, Heneghan MA. Current management of the hepatorenal syndrome. Hepatol Res. 2005;32:243–9.
Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology. 1996;23:164–76.
Gerbes AL, Gulberg V. Progress in treatment of massive ascites and hepatorenal syndrome. World J Gastroenterol. 2006;12:516–9.
Debray D, Yousef N, Durand P. New management options for end-stage chronic liver disease and acute liver failure: potential for pediatric patients. Paediatr Drugs. 2006;8:1–13.
Stravitz RT, Kramer AH, Davern T, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med. 2007;35:2498–508.
Sekido H, Matsuo K, Takeda K, et al. Impact of early enteral nutrition after liver transplantation for acute hepatic failure: report of four cases. Transplant Proc. 2003;35:369–71.
Shetty AK, Schmidt-Sommerfeld E, Udall Jr JN. Nutritional aspects of liver disease in children. Nutrition. 1999;15:727–9.
Hartley JL, Kelly DA. End stage liver failure. Paediatr Child Health. 2010;20:30–5.
Cordoba J, Lopez-Hellin J, Planas M, et al. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatol. 2004;41:38–43.
Tillmann HL, Hadem J, Leifeld L, et al. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J Viral Hepat. 2006;13:256–63.
Riediger C, Sauer P, Matevossian E, Muller MW, Buchler P, Friess H. Herpes simplex virus sepsis and acute liver failure. Clin Transplant. 2009;23 Suppl 21:37–41.
Marzullo L. An update of N-acetylcysteine treatment for acute acetaminophen toxicity in children. Curr Opin Pediatr. 2005;17:239–45.
Broussard CN, Aggarwal A, Lacey SR, et al. Mushroom poisoning–from diarrhea to liver transplantation. Am J Gastroenterol. 2001;96:3195–8.
Sogo T, Fujisawa T, Inui A, et al. Intravenous methylprednisolone pulse therapy for children with autoimmune hepatitis. Hepatol Res. 2006;34:187–92.
Clayton PT. Inborn errors presenting with liver dysfunction. Semin Neonatol. 2002;7:49–63.
Masurel-Paulet A, Poggi-Bach J, Rolland MO, Bernard O, Guffon N, Dobbelaere D, et al. NTBC treatment in tyrosinaemia type I: long-term outcome in French patients. J Inherit Metab Dis. 2008;31:81–7.
Joshi SN, Venugopalan P. Experience with NTBC therapy in hereditary tyrosinaemia type I: an alternative to liver transplantation. Ann Trop Paediatr. 2004;24:259–65.
Crone J, Moslinger D, Bodamer OA, et al. Reversibility of cirrhotic regenerative liver nodules upon NTBC treatment in a child with tyrosinaemia type I. Acta Paediatr. 2003;92:625–8.
Knisely AS, Mieli-Vergani G, Whitington PF. Neonatal hemochromatosis. Gastroenterol Clin North Am. 2003;32:877–89.
Karvellas CJ, Gibney N, Kutsogiannis D, Wendon J, Bain VG. Bench-to-bedside review: current evidence for extracorporeal albumin dialysis systems in liver failure. Crit Care. 2007;11:215.
Novelli G, Rossi M, Morabito V, et al. Pediatric acute liver failure with molecular adsorbent recirculating system treatment. Transplant Proc. 2008;40:1921–4.
Lee WM, Hynan LS, Rossaro L, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009;137:856–64. 64 e1.
Acharya SK, Bhatia V, Sreenivas V, Khanal S, Panda SK. Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study. Gastroenterology. 2009;136:2159–68.
Lee WS, McKiernan P, Kelly DA. Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United kingdom. J Pediatr Gastroenterol Nutr. 2005;40:575–81.
Lu BR, Gralla J, Liu E, Dobyns EL, Narkewicz MR, Sokol RJ. Evaluation of a scoring system for assessing prognosis in pediatric acute liver failure. Clin Gastroenterol Hepatol. 2008;6:1140–5.